← Latest Filings
G
Gilead Sciences, Inc.
Also a 13F filer: see its fund portfolio and quarterly moves →
Open-market buys
1
$2.0M total
Open-market sells
0
$0 total
Tracking since
Feb 2026
Activity timeline
Open-market buy — $2.0M
Xilio Therapeutics, Inc. · Feb 13, 2026
Open-market trades from the last two years.
Holdings as last reported
40,384,266 Prefunded Warrants (right to buy) in XLO
Held directly · as of 2026-02-13
4,977,089 Common Stock in ASMB
Held directly · as of 2026-05-26
Companies touched
ASSEMBLY BIOSCIENCES, INC.
CIK 0001426800
Xilio Therapeutics, Inc.
CIK 0001840233
